{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:20:44Z","timestamp":1793823644941,"version":"4.6.1"},"reference-count":126,"publisher":"Elsevier","isbn-type":[{"value":"9780128048184","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/bs.vh.2016.04.008","type":"book-chapter","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T18:59:55Z","timestamp":1464461995000},"page":"179-207","source":"Crossref","is-referenced-by-count":38,"title":["Prothymosin Alpha and Immune Responses"],"prefix":"10.1016","author":[{"given":"P.","family":"Samara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.E.","family":"Tsitsilonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.vh.2016.04.008_bb0005","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/205716a0","article-title":"Partial immunological restoration of neonatally thymectomized rats with thymus-containing diffusion chambers","volume":"205","author":"Aisenberg","year":"1965","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2016.04.008_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/08923979009019679","article-title":"Enhancement of human T lymphocyte function by prothymosin alpha: Increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes","volume":"12","author":"Baxevanis","year":"1990","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01533521","article-title":"Induction of lymphokine-activated killer activity in mice by prothymosin alpha","volume":"38","author":"Baxevanis","year":"1994","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/BF01525392","article-title":"Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha","volume":"40","author":"Baxevanis","year":"1995","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.2910530216","article-title":"Prothymosin alpha restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer","volume":"53","author":"Baxevanis","year":"1993","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.vh.2016.04.008_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002620050550","article-title":"Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin alpha","volume":"48","author":"Baxevanis","year":"1999","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0035","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4049\/jimmunol.148.7.1979","article-title":"Prothymosin alpha enhances human and murine MHC class II surface antigen expression and messenger RNA accumulation","volume":"148","author":"Baxevanis","year":"1992","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: All we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/956823","article-title":"Proteomic analysis of Pichind\u00e9 virus infection identifies differential expression of prothymosin-\u03b1","volume":"2010","author":"Bowick","year":"2010","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0050","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1073\/pnas.80.24.7424","article-title":"Thymosin alpha 11: A peptide related to thymosin alpha 1 isolated from calf thymosin fraction 5","volume":"80","author":"Caldarella","year":"1983","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0055","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1517\/14712598.2015.1033393","article-title":"Historical review of thymosin \u03b11 in infectious diseases","volume":"1","author":"Camerini","year":"2015","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0060","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s10495-013-0876-9","article-title":"Prothymosin alpha protects cardiomyocytes against ischemia-induced apoptosis via preservation of Akt activation","volume":"18","author":"Cannavo","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/bs.vh.2016.04.008_bb0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1440-1827.2006.01958.x","article-title":"Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays","volume":"56","author":"Carey","year":"2006","journal-title":"Pathology International"},{"key":"10.1016\/bs.vh.2016.04.008_bb0070","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI62423","article-title":"Alarmins: Awaiting a clinical response","volume":"122","author":"Chan","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2016.04.008_bb0075","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0192-0561(91)90156-2","article-title":"Prothymosin alpha enhances interleukin 2 receptor expression in normal human T-lymphocytes","volume":"13","author":"Cordero","year":"1991","journal-title":"International Journal of Immunopharmacology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0080","first-page":"277","article-title":"Prothymosin alpha enhances human natural killer cell cytotoxicity: Role in mediating signals for NK activity","volume":"11","author":"Cordero","year":"1992","journal-title":"Lymphokine and Cytokine Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0162-3109(95)00057-Z","article-title":"The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by Prothymosin-alpha","volume":"29","author":"Cordero","year":"1995","journal-title":"Immunopharmacology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0090","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/0024-3205(96)00157-9","article-title":"Binding of 125I-prothymosin alpha to lymphoblasts through the non-thymosin alpha 1 sequence","volume":"58","author":"Cordero","year":"1996","journal-title":"Life Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0095","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1073\/pnas.71.7.2637","article-title":"Thymosin corrects the abnormal DNA synthetic response of NZB mouse thymocytes","volume":"71","author":"Dauphinee","year":"1974","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0100","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0959-8049(05)80433-2","article-title":"Tissue concentrations of prothymosin alpha: A novel proliferation index of primary breast cancer","volume":"29A","author":"Dominguez","year":"1993","journal-title":"European Journal of Cancer"},{"key":"10.1016\/bs.vh.2016.04.008_bb0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0192-0561(95)00040-9","article-title":"Prothymosin alpha 1 modulates lymphokine-activated killer cell activity and IL-2 production by peripheral blood lymphocytes from melanoma patients in vitro","volume":"17","author":"Eckert","year":"1995","journal-title":"International Journal of Immunopharmacology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0192-0561(97)00079-9","article-title":"Preclinical studies with prothymosin alpha1 on mononuclear cells from tumor patients","volume":"19","author":"Eckert","year":"1997","journal-title":"International Journal of Immunopharmacology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0115","first-page":"420","article-title":"Interleukin-2-activated killer cell activity in colorectal tumor patients: Evaluation of in vitro effects by prothymosin alpha1","volume":"123","author":"Eckert","year":"1997","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1097-4652(200002)182:2<256::AID-JCP15>3.0.CO;2-N","article-title":"Functional discontinuities in prothymosin \u03b1 caused by caspase cleavage in apoptotic cells","volume":"182","author":"Enkemann","year":"2000","journal-title":"Journal of Cell Physiology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0125","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.83.24.9403","article-title":"The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: Evidence using a cloned cDNA","volume":"83","author":"Eschenfeldt","year":"1986","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-4827(02)00047-2","article-title":"Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha","volume":"284","author":"Evstafieva","year":"2003","journal-title":"Experimental Cell Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0135","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.cdd.4402189","article-title":"Prothymosin-alpha prevents necrosis and apoptosis following stroke","volume":"14","author":"Fujita","year":"2007","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/bs.vh.2016.04.008_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/cdd.2008.159","article-title":"Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition","volume":"16","author":"Fujita","year":"2009","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/bs.vh.2016.04.008_bb0145","first-page":"2405","article-title":"Prothymosin alpha augments deficient antitumor activity of monocytes from melanoma patients in vitro","volume":"14","author":"Garbin","year":"1994","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0150","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0192-0561(97)00024-6","article-title":"Prothymosin alpha 1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients","volume":"19","author":"Garbin","year":"1997","journal-title":"International Journal of Immunopharmacology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0155","doi-asserted-by":"crossref","first-page":"13211","DOI":"10.1021\/bi00040a037","article-title":"Prothymosin alpha: A biologically active protein with random coil conformation","volume":"34","author":"Gast","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/bs.vh.2016.04.008_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1415.045","article-title":"History of the discovery of the thymosins","volume":"1112","author":"Goldstein","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0165","first-page":"369","article-title":"Current status of thymosin and other hormones of the thymus gland","volume":"37","author":"Goldstein","year":"1981","journal-title":"Recent Progress in Hormone Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0170","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1073\/pnas.56.3.1010","article-title":"Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin)","volume":"56","author":"Goldstein","year":"1966","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3330001","article-title":"Prothymosin alpha is a chromatin-remodeling protein in mammalian cells","volume":"333","author":"Gomez-Marquez","year":"1998","journal-title":"Biochemical Journal"},{"key":"10.1016\/bs.vh.2016.04.008_bb0180","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1084\/jem.116.5.773","article-title":"The role of the thymus in development of immunologic capacity in rabbits and mice","volume":"116","author":"Good","year":"1962","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/bs.vh.2016.04.008_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1499-3872(14)60326-X","article-title":"Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma","volume":"14","author":"Ha","year":"2015","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"10.1016\/bs.vh.2016.04.008_bb0190","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/jnc.13356","article-title":"Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina","volume":"135","author":"Halder","year":"2015","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.vh.2016.04.008_bb0195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1471-4159.2012.07897.x","article-title":"Neuron-specific non-classical release of prothymosin alpha: A novel neuroprotective damage-associated molecular patterns","volume":"123","author":"Halder","year":"2012","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.vh.2016.04.008_bb0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.peptides.2013.02.022","article-title":"Therapeutic benefits of 9-amino acid peptide derived from prothymosin alpha against ischemic damages","volume":"43","author":"Halder","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/bs.vh.2016.04.008_bb0205","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0006-291X(82)91969-6","article-title":"Isolation of peptides from calf thymus","volume":"104","author":"Hannappel","year":"1982","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.vh.2016.04.008_bb0210","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1073\/pnas.79.6.1708","article-title":"Thymosins beta 8 and beta 9: Two new peptides isolated from calf thymus homologous to thymosin beta 4","volume":"79","author":"Hannappel","year":"1982","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0215","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0083-6729(03)01007-0","article-title":"The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: Structure and function","volume":"66","author":"Hannappel","year":"2003","journal-title":"Vitamins and Hormones"},{"key":"10.1016\/bs.vh.2016.04.008_bb0220","first-page":"123","article-title":"Alpha-thymosins: Relationships in structure, distribution, and function","volume":"14","author":"Haritos","year":"1987","journal-title":"Isozymes Current Top Biological & Medicinal Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0225","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1073\/pnas.81.4.1008","article-title":"Prothymosin alpha: Isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus","volume":"81","author":"Haritos","year":"1984","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0022-1759(85)90204-2","article-title":"A radioimmunoassay for thymosin alpha 1 that detects the native polypeptide, prothymosin alpha","volume":"81","author":"Haritos","year":"1985","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/bs.vh.2016.04.008_bb0235","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1073\/pnas.81.5.1391","article-title":"Distribution of prothymosin alpha in rat tissues","volume":"81","author":"Haritos","year":"1984","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0240","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0192-0561(97)00089-1","article-title":"Prothymosin alpha 1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients","volume":"19","author":"Heidecke","year":"1997","journal-title":"International Journal of Immunopharmacology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0245","first-page":"471","article-title":"Biochemical and immunological differentiation of human thymocytes induced by thymic hormones","volume":"50","author":"Ho","year":"1983","journal-title":"Immunology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1975.tb29063.x","article-title":"Purification and properties of bovine thymosin","volume":"249","author":"Hooper","year":"1975","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0255","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2172-14-43","article-title":"Prothymosin \u03b1 and a prothymosin \u03b1-derived peptide enhance T(H)1-type immune responses against defined HER-2\/neu epitopes","volume":"14","author":"Ioannou","year":"2013","journal-title":"BMC Immunology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0260","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00262-012-1222-8","article-title":"Prothymosin alpha: A ubiquitous polypeptide with potential use in cancer diagnosis and therapy","volume":"61","author":"Ioannou","year":"2012","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0265","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1076807","article-title":"Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway","volume":"299","author":"Jiang","year":"2003","journal-title":"Science"},{"key":"10.1016\/bs.vh.2016.04.008_bb0270","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/CDLI.12.12.1364-1369.2005","article-title":"Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid","volume":"12","author":"Jin","year":"2005","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0275","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.urology.2008.11.060","article-title":"Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinoma","volume":"74","author":"Jou","year":"2009","journal-title":"Urology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.03.031","article-title":"Specific in vitro binding of a new (99m)Tc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophils","volume":"486","author":"Karachaliou","year":"2015","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/bs.vh.2016.04.008_bb0285","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/embo-reports\/kvf071","article-title":"Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription","volume":"3","author":"Karetsou","year":"2002","journal-title":"EMBO Reports"},{"key":"10.1016\/bs.vh.2016.04.008_bb0290","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/pr100529t","article-title":"Secretome-based identification and characterization of potential biomarkers in thyroid cancer","volume":"9","author":"Kashat","year":"2010","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/bjc.1973.150","article-title":"Immunotherapy of the Dunning leukemia with thymic extracts","volume":"28","author":"Khaw","year":"1973","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.vh.2016.04.008_bb0300","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1073\/pnas.53.4.812","article-title":"Enhancement of in vivo incorporation of labeled precursors into DNA and total protein of mouse lymph nodes after administration of thymic extracts","volume":"53","author":"Klein","year":"1965","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0305","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1369\/jhc.2008.950956","article-title":"Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody","volume":"56","author":"Klimentzou","year":"2008","journal-title":"The Journal of Histochemistry and Cytochemistry"},{"key":"10.1016\/bs.vh.2016.04.008_bb0310","first-page":"57","article-title":"Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: Novel proliferation markers?","volume":"54","author":"Letsas","year":"2007","journal-title":"Neoplasma"},{"key":"10.1016\/bs.vh.2016.04.008_bb0315","first-page":"199","article-title":"Evidence for function of thymic tissue in diffusion chambers implanted in neonatally thymectomized mice. Preliminary report","volume":"31","author":"Levey","year":"1963","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/bs.vh.2016.04.008_bb0320","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.surg.2006.05.009","article-title":"Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer","volume":"141","author":"Leys","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/bs.vh.2016.04.008_bb0325","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1523-1755.2005.00268.x","article-title":"Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease","volume":"67","author":"Li","year":"2005","journal-title":"Kidney International"},{"key":"10.1016\/bs.vh.2016.04.008_bb0330","first-page":"175","article-title":"Interleukin-2 killer cells: In vitro evaluation of combination with prothymosin alpha","volume":"13","author":"L\u00f3pez-Rodr\u00edguez","year":"1994","journal-title":"Lymphokine and Cytokine Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0335","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1073\/pnas.78.2.1162","article-title":"Complete amino acid sequence of bovine thymosin beta 4: A thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations","volume":"78","author":"Low","year":"1981","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0340","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1054\/bjoc.1999.0968","article-title":"Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer","volume":"82","author":"Magdalena","year":"2000","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.vh.2016.04.008_bb0345","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4049\/jimmunol.160.2.1001","article-title":"Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing","volume":"160","author":"Malinda","year":"1998","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0350","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/S0021-9258(19)67881-6","article-title":"Nuclear targeting of prothymosin alpha","volume":"266","author":"Manrow","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2016.04.008_bb0355","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/cdd.2010.52","article-title":"Stress-induced non-vesicular release of prothymosin-\u03b1 initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage","volume":"17","author":"Matsunaga","year":"2010","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/bs.vh.2016.04.008_bb0360","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0140-6736(61)90693-6","article-title":"Immunological function of the thymus","volume":"2","author":"Miller","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/bs.vh.2016.04.008_bb0365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1600-065X.2002.18502.x","article-title":"The discovery of thymus function and of thymus-derived lymphocytes","volume":"185","author":"Miller","year":"2002","journal-title":"Immunology Reviews"},{"key":"10.1016\/bs.vh.2016.04.008_bb0370","first-page":"2821","article-title":"Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer","volume":"8","author":"Mori","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/bs.vh.2016.04.008_bb0375","doi-asserted-by":"crossref","first-page":"10178","DOI":"10.1073\/pnas.0914870107","article-title":"Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction","volume":"107","author":"Mosoian","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0380","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1128\/JVI.00589-06","article-title":"Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages","volume":"80","author":"Mosoian","year":"2006","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.taap.2009.06.009","article-title":"Nrf2 signaling and cell survival","volume":"244","author":"Niture","year":"2010","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0390","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1517\/14712598.2015.1005597","article-title":"Evidence for ProT\u03b1-TLR4\/MD-2 binding: Molecular dynamics and gravimetric assay studies","volume":"1","author":"Omotuyi","year":"2015","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0395","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0003-9861(86)90717-4","article-title":"Human prothymosin alpha: Amino acid sequence and immunologic properties","volume":"250","author":"Pan","year":"1986","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.vh.2016.04.008_bb0400","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01741862","article-title":"Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha","volume":"35","author":"Papanastasiou","year":"1992","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(02)02572-3","article-title":"Amyloid fibrils from the mammalian protein prothymosin alpha","volume":"517","author":"Pavlov","year":"2002","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.vh.2016.04.008_bb0410","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5603\/EP.2014.0053","article-title":"Overexpression of prothymosin alpha is related to pituitary adenoma recurrence but not to adenoma invasiveness and proliferation","volume":"65","author":"Pawlikowski","year":"2014","journal-title":"Endokrynologia Polska"},{"key":"10.1016\/bs.vh.2016.04.008_bb0415","first-page":"2139","article-title":"Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB\/c mice treated in vivo with thymosin fraction V","volume":"42","author":"Petro","year":"1982","journal-title":"Cancer Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0420","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1515\/BC.2001.181","article-title":"Identification of receptors for prothymosin alpha on human lymphocytes","volume":"382","author":"Pi\u00f1eiro","year":"2001","journal-title":"Biological Chemistry"},{"key":"10.1016\/bs.vh.2016.04.008_bb0425","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0196-9781(00)00288-6","article-title":"Fifteen years of prothymosin alpha: Contradictory past and new horizons","volume":"21","author":"Pi\u00f1eiro","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/bs.vh.2016.04.008_bb0430","first-page":"326","article-title":"Effect of recombinant prothymosin alpha on secretion of IFN-gamma, IFN-alpha and TNF-alpha in vitro","volume":"37","author":"Qiu","year":"2002","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/bs.vh.2016.04.008_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06716.x","article-title":"Jack of all trades: Thymosin \u03b11 and its pleiotropy","volume":"1269","author":"Romani","year":"2012","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(97)00824-7","article-title":"Mutational analysis of human prothymosin alpha reveals a bipartite nuclear localization signal","volume":"413","author":"Rubtsov","year":"1997","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.vh.2016.04.008_bb0445","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09687860500063506","article-title":"Prothymosin alpha-receptor associates with lipid rafts in PHA-stimulated lymphocytes","volume":"22","author":"Salgado","year":"2005","journal-title":"Molecular Membrane Biology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0450","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2012.11.011","article-title":"The C-terminal decapeptide of prothymosin \u03b1 is responsible for its stimulatory effect on the functions of human neutrophils in vitro","volume":"15","author":"Samara","year":"2013","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0455","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jim.2013.06.011","article-title":"Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin \u03b1(100-109) in sera of mice infected with bacteria","volume":"395","author":"Samara","year":"2013","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/bs.vh.2016.04.008_bb0460","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s005950170040","article-title":"Expression of the prothymosin-alpha gene as a prognostic factor in lung cancer","volume":"31","author":"Sasaki","year":"2001","journal-title":"Surgery Today"},{"key":"10.1016\/bs.vh.2016.04.008_bb0465","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3835(01)00540-7","article-title":"Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma","volume":"168","author":"Sasaki","year":"2001","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.vh.2016.04.008_bb0470","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/1046-5928(90)90014-P","article-title":"Human prothymosin alpha: Purification of a highly acidic nuclear protein by means of a phenol extraction","volume":"1","author":"Sburlati","year":"1990","journal-title":"Protein Expression and Purification"},{"key":"10.1016\/bs.vh.2016.04.008_bb0475","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1073\/pnas.88.1.253","article-title":"Prothymosin alpha antisense oligomers inhibit myeloma cell division","volume":"88","author":"Sburlati","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0480","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/08916934.2012.750302","article-title":"During apoptosis HMGB1 is translocated into apoptotic cell-derived membranous vesicles","volume":"46","author":"Schiller","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/bs.vh.2016.04.008_bb0485","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.molimm.2008.09.014","article-title":"Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner","volume":"46","author":"Skopeliti","year":"2009","journal-title":"Molecular Immunology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0490","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/pmic.200600870","article-title":"Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation","volume":"7","author":"Skopeliti","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/bs.vh.2016.04.008_bb0495","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00262-005-0108-4","article-title":"The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients","volume":"55","author":"Skopeliti","year":"2006","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0500","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1749-6632.2000.tb05425.x","article-title":"Interleukin-1\u03b2 and thymic peptide regulation of pituitary and glial cell cytokine expression and cellular proliferation","volume":"917","author":"Spangelo","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0505","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1749-6632.1987.tb35766.x","article-title":"Biology and chemistry of thymosin peptides. Modulators of immunity and neuroendocrine circuits","volume":"496","author":"Spangelo","year":"1987","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0510","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1196\/annals.1415.022","article-title":"Thymosin fraction-5 possesses antiproliferative properties in HL-60 human promyelocytic leukemia cells: Characterization of an active peptide","volume":"1112","author":"Spangelo","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0515","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1210\/jc.2015-2277","article-title":"Prothymosin-\u03b1 overexpression contributes to the development of insulin resistance","volume":"100","author":"Su","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2016.04.008_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2906","article-title":"Prothymosin \u03b1 overexpression contributes to the development of pulmonary emphysema","volume":"4","author":"Su","year":"2013","journal-title":"Nature Communications"},{"key":"10.1016\/bs.vh.2016.04.008_bb0525","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/path.4664","article-title":"Over-expression of prothymosin-\u03b1 antagonizes TGF\u03b2 signalling to promote the development of emphysema","volume":"238","author":"Su","year":"2016","journal-title":"Journal of Pathology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0530","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/pros.20385","article-title":"Expression of prothymosin alpha is correlated with development and progression in human prostate cancers","volume":"66","author":"Suzuki","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/bs.vh.2016.04.008_bb0535","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0006-291X(92)91719-7","article-title":"Prothymosin alpha expression occurs during G1 in proliferating B or T lymphocytes","volume":"185","author":"Szabo","year":"1992","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.vh.2016.04.008_bb0540","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF00202480","article-title":"Prothymosin alpha gene in humans: Organization of its promoter region and localization to chromosome 2","volume":"90","author":"Szabo","year":"1993","journal-title":"Human Genetics"},{"key":"10.1016\/bs.vh.2016.04.008_bb0545","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00205510","article-title":"Immunomodulation and therapeutic characterization of thymosin fraction five","volume":"18","author":"Talmadge","year":"1984","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0550","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/infdis\/jiu643","article-title":"Prothymosin \u03b1 variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction","volume":"211","author":"Teixeira","year":"2015","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/bs.vh.2016.04.008_bb0555","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/intimm\/dxl089","article-title":"Dendritic cell activating peptides induce distinct cytokine profiles","volume":"18","author":"Telusma","year":"2006","journal-title":"International Immunology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0560","doi-asserted-by":"crossref","first-page":"e19213","DOI":"10.1371\/journal.pone.0019213","article-title":"Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer","volume":"6","author":"Tripathi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2016.04.008_bb0565","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00428-014-1578-6","article-title":"Loss of nuclear prothymosin-\u03b1 expression is associated with disease progression in human superficial bladder cancer","volume":"464","author":"Tsai","year":"2014","journal-title":"Virchows Archiv"},{"key":"10.1016\/bs.vh.2016.04.008_bb0570","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1073\/pnas.90.20.9504","article-title":"Expression of alpha-thymosins in human tissues in normal and abnormal growth","volume":"90","author":"Tsitsiloni","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2016.04.008_bb0575","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF01957467","article-title":"Prothymosin alpha is not a nuclear polypeptide","volume":"45","author":"Tsitsiloni","year":"1989","journal-title":"Experientia"},{"key":"10.1016\/bs.vh.2016.04.008_bb0580","first-page":"1501","article-title":"The prognostic value of alpha-thymosins in breast cancer","volume":"18","author":"Tsitsilonis","year":"1998","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.vh.2016.04.008_bb0585","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pharmthera.2009.05.007","article-title":"Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage","volume":"123","author":"Ueda","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.vh.2016.04.008_bb0590","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1083\/jcb.200608022","article-title":"Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures","volume":"176","author":"Ueda","year":"2007","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0595","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s002620000132","article-title":"Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas","volume":"49","author":"Voutsas","year":"2000","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.vh.2016.04.008_bb0600","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ejca.2012.11.037","article-title":"Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin \u03b1 or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice","volume":"49","author":"Voutsas","year":"2013","journal-title":"European Journal of Cancer"},{"key":"10.1016\/bs.vh.2016.04.008_bb0605","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1749-6632.1975.tb29078.x","article-title":"Activation of T-cell rosettes in immunodeficient patients by thymosin","volume":"249","author":"Wara","year":"1975","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0610","doi-asserted-by":"crossref","first-page":"e1002352","DOI":"10.1371\/journal.ppat.1002352","article-title":"Type 1 interferons and antiviral CD8 T-cell responses","volume":"8","author":"Welsh","year":"2012","journal-title":"PLoS Pathogen"},{"key":"10.1016\/bs.vh.2016.04.008_bb0615","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/bjc.1997.533","article-title":"Overexpression of hepatic prothymosin alpha, a novel marker for hepatocellular carcinoma","volume":"76","author":"Wu","year":"1997","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.vh.2016.04.008_bb0620","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/S0024-3205(97)00882-5","article-title":"Prothymosin alpha promotes cell proliferation in NIH3T3 cells","volume":"61","author":"Wu","year":"1997","journal-title":"Life Sciences"},{"key":"10.1016\/bs.vh.2016.04.008_bb0625","first-page":"4867","article-title":"Increased expression of prothymosin-\u03b1, independently or combined with TP53, correlates with poor prognosis in colorectal cancer","volume":"7","author":"Zhang","year":"2014","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.1016\/bs.vh.2016.04.008_bb0630","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.dci.2015.07.004","article-title":"Tongue sole (Cynoglossus semilaevis) prothymosin alpha: Cytokine-like activities associated with the intact protein and the C-terminal region that lead to antiviral immunity via Myd88-dependent and -independent pathways respectively","volume":"53","author":"Zhang","year":"2015","journal-title":"Developmental & Comparative Immunology"}],"container-title":["Vitamins and Hormones","Thymosins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672916300218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672916300218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T06:14:26Z","timestamp":1718604866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672916300218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128048184"],"references-count":126,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2016.04.008","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}